ロード中...
Progress in the Development of Anti-tissue Factor Pathway Inhibitors for Haemophilia Management
The unprecedented progress in addressing unmet needs in haemophilia care to date includes developing several novel therapies that rebalance haemostasis by restoring thrombin generation in patients with haemophilia A or B with and without inhibitors. These novel therapies are FVIII mimetics, antithro...
保存先:
| 出版年: | Front Med (Lausanne) |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8131856/ https://ncbi.nlm.nih.gov/pubmed/34026796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.670526 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|